Reproductive Health in the Trump Era: Implications of Recent Federal and Judicial Action
KFF’s Alina Salganicoff and Laurie Sobel led a web briefing to explain what this flurry of federal activity may mean for women, their providers, and future policy directions.
The Myth Of The Abortion Insurance Rider
In Health Affairs, KFF experts discuss the feasibility of abortion riders to private group and individual health plans as a means of providing access to abortion coverage when states ban the coverage as part of an insurance plan.
Proposed Changes to Title X: Implications for Women and Family Planning Providers
The Trump Administration proposed new regulations in June for the Federal Title X family planning program that could significantly impact the network of providers currently available to low-income women.
Abortion Coverage in the Senate Bipartisan Health Care Stabilization Act of 2018
Under the Senate ACA stabilization bill only insurers that exclude abortion coverage would be eligible for:
– Federal reinsurance funding,
– Invisible high-risk pools, and
– Cost-sharing reduction payments
Abortion Riders in States with Insurance Restrictions
- 10 states ban abortion coverage in most private plans
- 9 of these states allow sale of abortion riders
- No insurers offer abortion riders on individual market in these states
Changes to Contraceptive Coverage Rule: Exemptions & Accommodations
- Which employers are exempt from providing contraceptive coverage without cost sharing.
- What type of employers may seek an “accommodation” to avoid paying for contraceptives in their plans.
Medicaid’s Role for Women
Changes to the program’s financing and structure could have significant implications for low-income women’s access to coverage and care.
Fact Sheet: Medication Abortion
Even as overall rates of abortion decline, the use of medication abortion has grown significantly since its approval by the FDA.
Interactive
State Profiles for Women’s Health
